结肠直肠癌向治疗的进展:克服挑战并探索未来的方向
Said A Khelwatty1, Soozana Puvanenthiran2, Alan M Seddon1
1School of Life Science, Pharmacy and Chemistry, Kingston University London, London KT1 2EE, UK.
Cancers
|September 13, 2025
概括
包括HER抑制剂在内的向疗法为结直肠癌 (CRC) 患者提供了新的希望. 克服耐药性和改善生物标志物发现是提高治疗有效性和患者结果的关键.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症治疗方法 癌症治疗方法
背景情况:
- 结肠直肠癌 (CRC) 是一个主要的全球健康挑战,高级阶段往往被诊断为晚期.
- 有效和少毒的治疗目标对于改善先进CRC的结果至关重要.
研究的目的:
- 审查最近针对结直肠癌的向治疗方法的进展,重点关注 HER 抑制剂.
- 评估单克隆抗体 (mAbs) 和氨酸激酶抑制剂 (TKIs) 的疗效,并探索耐药性机制.
- 讨论未来的方向,包括新的生物标志物和组合疗法.
主要方法:
- 关于结直肠癌向治疗的当前文献的综述.
- 对HER抑制剂 (mAbs,TKI) 的疗效和耐药性机制的评估.
- 探索新兴的治疗策略,如双TKI,ADC,双特异性抗体和CAR-T细胞.
主要成果:
- 针对性疗法,如 cetuximab 和 panitumumab 已在 KRAS 野生型 CRC 中显示出有效性.
- 抵抗机制和瘤异质性带来了重大挑战.
- 诸如双重TKI,ADC,双特异性抗体和CAR-T细胞等新的方法显示出有前途.
结论:
- 向疗法已经改变了CRC的治疗方法,但仍然存在挑战.
- 需要进一步的研究来解决晚期诊断,瘤异质性和生物标志物发现的问题.
- 未来的方向包括开发下一代抑制剂,药物重用和免疫疗法组合.
更多相关视频
08:59Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down
Published on: December 11, 2017
7.6K
03:05Author Spotlight: Advancing Early Detection and Treatment of Gastrointestinal Tumors
Published on: February 16, 2024
1.5K
相关概念视频
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
Combination Therapies and Personalized Medicine
5.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.9K
Cancer Therapies
9.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.8K
Tumor Immunotherapy
1.8K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.8K
Tumor Progression
7.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.2K
